RecruitingNot ApplicableNCT06296550

Enhancing Digitally Delivered Diabetes Education With Real-Time CGM

Enhancing Digitally Delivered Diabetes Education With Real-Time CGM: A Comparative Study in People With Type 2 Diabetes


Sponsor

Scripps Whittier Diabetes Institute

Enrollment

140 participants

Start Date

Apr 3, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Diagnosed with type 2 diabetes
  • Are not currently using a CGM
  • Are not using insulin therapies
  • Speak English, Spanish or Arabic
  • Have A1c between 7.5% and 12.0% in last 90 days
  • Have a cellphone that can receive/send text messages and counts steps

Exclusion Criteria4

  • Are using insulin therapies
  • Are pregnant
  • Are currently using a CGM
  • Are currently participating in another diabetes-related study

Interventions

OTHERDulce Digital Text Messaging Intervention

Text-based education support program: * Participants will receive text messages about diabetes and how to take care of diabetes and health. Participants will receive 2-3 messages every day for first 3 months, and then will slowly decrease over the last 3-months. * Participants will also receive text messages that will ask them to test their blood sugar and text back blood sugar reading.

OTHERCGM Device

Participants will be provided continuous glucose monitors (Dexcom G7) to actively monitor blood glucose for the entire duration of this study (i.e., one new device every 10 days for a total of 18 devices to last up to 6 months). In addition, participants will attend an information session (group or individual; in-person or virtual) that will provide instructions on using continuous glucose monitors.


Locations(1)

Scripps Whittier Diabetes Institute

San Diego, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06296550


Related Trials